Drug Trial Radar · NCT02749656
Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
Last checked: Nov 20, 2026Latest source record: May 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
105
Planned (sponsor's estimate)
Start
Jan 1, 2016
Primary completion
Jan 2018
Study completion Dec 2018
Sponsor
- Lead sponsor
- Siriraj HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- SPS MEDICAL CO.,LTD.; Siriraj clinical research center
- First posted
- Apr 25, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate efficacy and safety of 0.25% Desoximetasone cream (Topoxy®) compare with 0.25% Desoximetasone cream (Topicorte®) in the treatment of scalp psoriasis.
Conditions
- Scalp Psoriasis
Interventions
0.25% Desoximetasone cream (Topoxy®)Drug
apply on the scalp psoriasis lesion twice a day
0.25% Desoximetasone cream (Topicorte®)Drug
apply on the scalp psoriasis lesion twice a day
PlaceboDrug
apply on the scalp psoriasis lesion twice a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of Investigator's Global Assessment score (IGA) after treatmentTime frame: 2, 4 and 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of dermatology Faculty of Medicine Siriraj Hospital
Bangkok, Thailand · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.